loading

Axsome Therapeutics Inc Azioni (AXSM) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
23.53%
150.04
121.46 118.77 104.76 87.17
Operating Expenses
4.66%
186.76
178.44 191.38 167.39 165.21
Interest Income/Expense
22.29%
-4.086
-5.258 - - -
Benefits Costs and Expenses
10.01%
198.97
180.88 193.59 169.36 166.51
Costs And Expenses
4.66%
186.76
178.44 191.38 167.39 165.21
Operating Income/Loss
35.57%
-36.71
-56.98 -72.62 -62.62 -78.05
Income/Loss From Continuing Operations Before Tax
17.64%
-48.93
-59.41 -74.83 -64.60 -79.34
Income Tax Expense/Benefit
-0.96
- 0.085 - -
Income/Loss From Continuing Operations After Tax
19.26%
-47.97
-59.41 -74.91 -64.60 -79.34
Net Income/Loss
19.26%
-47.97
-59.41 -74.91 -64.60 -79.34
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.17%
49.44
48.87 0.2107 48.14 47.57
Diluted Average Shares
1.17%
49.44
48.87 0.2107 48.14 47.57
Basic Earnings Per Share
20.49%
-0.97
-1.22 -1.54 -1.34 -1.67
Diluted Earnings Per Share
20.49%
-0.97
-1.22 -1.54 -1.34 -1.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.27
price down icon 14.24%
$86.42
price up icon 0.06%
$27.40
price down icon 0.84%
$108.26
price down icon 2.97%
$145.56
price up icon 0.38%
biotechnology ONC
$341.94
price up icon 0.16%
Capitalizzazione:     |  Volume (24 ore):